top of page

News 

Resources News

Discover the latest news, blogs, articles and interviews from GeneFirst.

Exploring why the quality of oligos can have a significant impact on NGS assay performance.

4 Aug 2026

1.91-1_placeholder.png

Why High-Quality Oligos Matter for Reliable Sarcoma Fusion Detection

How ATOM-Seq enables detection of unknown fusions

22 Jul 2026

1.91-1_placeholder.png

Rising to the challenge of unknown fusion detection in oncology

How molecular diagnostics is transforming our understanding of sarcomas, one of the rarest and most complex groups of cancers.

17 Jul 2026

1.91-1_placeholder.png

Sarcoma Awareness Month: A Rare and Complex Group of Cancers

The guidance highlights the growing importance of HPV DNA genotyping in risk-based cervical screening strategies.

24 Jun 2026

1.91-1_placeholder.png

WHO guidance on HPV genotyping in cervical cancer screening

Novel approach to cancer liquid biopsy testing can detect even the rarest cancer-related mutations.

17 Jun 2026

1.91-1_placeholder.png

Second-generation XCeloSeq cell-free DNA library preparation kits

GeneFirst Receives Thai FDA Approval for Papilloplex® HR-HPV DNA and mRNA Kits

9 Jun 2026

1.91-1_placeholder.png

Thai FDA Approval

GeneFirst announces the publication of new health economic evidence showing …

7 Jul 2023

1.91-1_placeholder.png

Health economic evidence for pneumonia testing cost savings

Harnessing the Potential of Genomics: Empowering Cancer Care through Inherited Mutations and Equitable Access to Genomic Testing

6 Jun 2023

1.91-1_placeholder.png

Harnessing the Potential of Genomics

Unleashing the Power of Genome Sequencing in Drug Discovery: Innovative Approaches to 'Drug the Undruggable'

25 May 2023

1.91-1_placeholder.png

Unleashing the Power of Genome Sequencing in Drug Discovery

Advancing Cervical Cancer Prevention: GeneFirst's Breakthrough in Cervical Screening

25 May 2023

1.91-1_placeholder.png

GeneFirst's Breakthrough in Cervical Screening

GeneFirst is attending the Med-Tech Innovation Expo 2023

26 Apr 2023

1.91-1_placeholder.png

GeneFirst is attending the Med-Tech Innovation Expo 2023

Screening innovations strengthen fight against cervical cancer

26 Apr 2023

1.91-1_placeholder.png

Screening innovations strengthen fight against cervical cancer

FFPE: The Foundation of Clinical Genomics Research

20 Apr 2023

1.91-1_placeholder.png

FFPE: The Foundation of Clinical Genomics Research

Reflecting on National Women's History Month

30 Mar 2023

1.91-1_placeholder.png

Reflecting on National Women's History Month

Thought piece: Cancer in the UK: Overview 2023

30 Mar 2023

1.91-1_placeholder.png

Thought piece: Cancer in the UK: Overview 2023

Reflecting on Myeloma Awareness Month

22 Mar 2023

1.91-1_placeholder.png

Myeloma Awareness Month

World Cancer Day: The Importance of Raising Awareness about Blood Cancer

22 Mar 2023

1.91-1_placeholder.png

Raising Awareness about Blood Cancer

Revolutionising Cancer Diagnostics: The Many Applications of Liquid Biopsies

8 Mar 2023

1.91-1_placeholder.png

Revolutionising Cancer Diagnostics liquid biopsies

Get Acquainted with Liquid Biopsies

8 Mar 2023

1.91-1_placeholder.png

Get Acquainted With Liquid Biopsies

Four ways to spread awareness during Ovarian Cancer Awareness Month

2 Mar 2023

1.91-1_placeholder.png

Ovarian Cancer Awareness Month 2023

Eurogin 2023 - That's a wrap!

16 Feb 2023

1.91-1_placeholder.png

Eurogin 2023 Thats A Wrap

We're in Bilbao, Spain for Eurogin 2023

7 Feb 2023

1.91-1_placeholder.png

Eurogin Bilbao 2023

GeneFirst is attending Eurogin 2023

25 Jan 2023

1.91-1_placeholder.png

GeneFirst Attending Eurogin 2023

The story of HPV

19 Dec 2022

1.91-1_placeholder.png

The Story of HPV

Medica 2022, Dusseldorf

23 Nov 2022

1.91-1_placeholder.png

Medica 2022 Dusseldorf

GeneFirst at NextGen Omics 2022

23 Nov 2022

1.91-1_placeholder.png

GeneFirst at NextGen Omics 2022

Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection

3 Dec 2021

1.91-1_placeholder.png

Papilloplex HR-HPV Clinical Validation

GeneFirst COVID-19 kits and new Variant of Concern, Omicron

2 Dec 2021

1.91-1_placeholder.png

GeneFirst COVID-19 Kits and New Variant of Concern Omicron

GeneFirst will be attending Medica 2021 in Düsseldorf

10 Nov 2021

1.91-1_placeholder.png

GeneFirst Attending Medica 2021

Innovative UK SME GeneFirst and University of Leeds win £1.4M …

22 Feb 2021

1.91-1_placeholder.png

NIHR grant award

NEW publication on the utility of GeneFirst’s ATOM-Seq™ NGS library preparation technology for use with cfDNA and cfRNA

5 Feb 2021

1.91-1_placeholder.png

ATOM-Seq Paper

GeneFirst develops Real-Time PCR tests for detection of the new coronavirus 2019-nCoV

3 Feb 2020

1.91-1_placeholder.png

New Covid Test

NEW publication on the analytical performance of Papilloplex HR-HPV

18 Jun 2019

1.91-1_placeholder.png

Papilloplex HR-HPV publication

GeneFirst wins €2.9m Horizon 2020 grant to deliver predictive diagnostic panel for HPV infections evolving into cervical cancer

30 Sept 2018

1.91-1_placeholder.png

Horizon 2020 HPV

GeneFirst wins second major Innovate UK competitive grant to improve cancer treatment using its ATOM-seq™ NGS technology

25 Oct 2017

1.91-1_placeholder.png

Innovate ATOM-Seq

GeneFirst wins Innovate UK’s Shanghai-UK competition for the development of non-invasive test for cancer

27 Sept 2017

1.91-1_placeholder.png

Innovate Shanghai Grant

bottom of page